Curtis Gale Oltmans Avenue Therapeutics, Inc. (ATXI) insider trading activity

Curtis Gale Oltmans is Director of AVENUE THERAPEUTICS, INC.. Currently has a direct ownership of 49,020 shares of ATXI, which is worth approximately $120,099. The most recent transaction as insider was on Dec 17, 2021, when has been sold 49,020 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49K

0% 3M change

0% 12M change

Total Value Held $120,099

Curtis Gale Oltmans Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 17 2021	BUY Grant, award, or other acquisition	-	49,020 Added 50.0%	49,020 Common Stock

Also insider at

FULC

Fulcrum Therapeutics, Inc. Healthcare

Chief Legal Officer

CGO